{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:36:03Z","timestamp":1791329763326,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7572,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1023\/a:1008301602785","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"433-440","source":"Crossref","is-referenced-by-count":134,"title":["Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival"],"prefix":"10.1016","volume":"10","author":[{"given":"A.H.","family":"Sarris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-O.","family":"Kliche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pethambaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jackow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.B.","family":"Hagemeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008301602785_bb0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.1986.4.9.1295","article-title":"Twenty years of MOPP therapy for Hodgkin\u2019s disease","volume":"4","author":"Longo","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008301602785_bb0010","series-title":"Cancer, Principles & Practice of Oncology","article-title":"Hodgkin\u2019s disease","author":"De Vita","year":"1993"},{"key":"10.1023\/A:1008301602785_bb0015","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008301602785_bb0020","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1200\/JCO.1990.8.7.1173","article-title":"Prognostic factors among 185 adults with newly diagnosed advanced Hodgkm\u2019s disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy","volume":"8","author":"Straus","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008301602785_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10428199209061558","article-title":"A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkm\u2019s disease at diagnosis The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party","volume":"7","author":"Proctor","year":"1992","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1008301602785_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10428199509052700","article-title":"Prognostic factors in advanced Hodgkin\u2019s disease: Problems and pitfalls. Towards an international prognostic index","volume":"1","author":"Gisselbrecht","year":"1995","journal-title":"Leuk Lymph"},{"issue":"Suppl 3","key":"10.1023\/A:1008301602785_bb0035","first-page":"112","article-title":"Advanced Hodgkin\u2019s disease: Validation of the MSKCC prognostic model. How to identify a high-risk group qualifying for intensive initial treatment?","volume":"7","author":"Ferme","year":"1996","journal-title":"The GELA study Ann Oncol"},{"key":"10.1023\/A:1008301602785_bb0040","first-page":"893a","article-title":"A prognostic model for advanced Hodgkin\u2019s disease at M.D. Anderson validated with an independent set of patients treated at Memorial Sloan-Kettering","volume":"88","author":"Sarris","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0045","first-page":"7a","article-title":"A Prognostic model for failure-free survival (FFS) of adults with clinical Ann Arbor stage (AAS) I-II Hodgkin\u2019s disease (HD) after combined modality therapy","volume":"16","author":"Sarris","year":"1997","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1023\/A:1008301602785_bb0050","first-page":"388a","article-title":"A predictive model for failure-free survival (FFS) of adults with Hodgkin\u2019s disease treated with ABVD or equivalent regimens","volume":"90","author":"Sarris","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0055","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A progostic score for advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008301602785_bb0060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin\u2019s disease and Ki\u20131-positive anaplastic large-cell lymphoma by combined Southern blot and in situ hybridization","volume":"74","author":"Anagnostopoulos","year":"1989","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711680405","article-title":"Epstein-Barr virus (EBV) and Hodgkin\u2019s disease in children: Incidence of EBV latent membrane protein in malignant cells","volume":"168","author":"Weinreb","year":"1992","journal-title":"J Pathol"},{"key":"10.1023\/A:1008301602785_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood.V81.2.462.462","article-title":"Epstein-Barr virus and childhood Hodgkin\u2019s disease in Honduras and the United States","volume":"81","author":"Ambinder","year":"1993","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V81.2.496.496","article-title":"High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin\u2019s disease occurring in Peru","volume":"81","author":"Chang","year":"1993","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0080","first-page":"675","article-title":"Association of Epstein-Barr virus latent membrane protein and Hodgkin\u2019s disease in Mexico","volume":"8","author":"Quintanilla-Martinez","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1023\/A:1008301602785_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ijc.2910620103","article-title":"Human and viral interleukin\u201310 in Hodgkin\u2019s disease, and its influence on CD4+ and CD8+ T lymphocytes","volume":"62","author":"Ohshima","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008301602785_bb0090","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V87.9.3828.bloodjournal8793828","article-title":"The consistent association between Epstein-Barr virus and Hodgkin\u2019s disease in children in Kenya","volume":"87","author":"Weinreb","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<949::AID-CNCR22>3.0.CO;2-2","article-title":"A pathologic study of Hodgkin\u2019s disease in Korea and its association with Epstein-Barr virus infection","volume":"77","author":"Huh","year":"1996","journal-title":"Cancer"},{"key":"10.1023\/A:1008301602785_bb0100","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V87.7.2918.bloodjournal8772918","article-title":"Frequent expression of Interleukin\u201310 by Epstein-Barr virus-harboring tumor cells of Hodgkin\u2019s disease","volume":"87","author":"Herbst","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1008301602785_bb0105","first-page":"353a","article-title":"The expression of the EBV-coded latent membrane protein\u20131 (LMP\u20131) In Reed-Sternberg cells of Hodgkin\u2019s disease (HD) is associated with higher serum IL\u201310 levels and inferior failure-free survival (FFS)","volume":"92","author":"Sarris","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0110","first-page":"1683","article-title":"Association of Epstein-Barr virus with pediatric Hodgkin\u2019s disease","volume":"142","author":"Armstrong","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1023\/A:1008301602785_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/345447a0","article-title":"Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus","volume":"345","author":"Fahraeus","year":"1990","journal-title":"Nature"},{"key":"10.1023\/A:1008301602785_bb0120","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/344777a0","article-title":"Epstem-Barr virus latent membrane protein inhibits human epithelial cell differentiation","volume":"344","author":"Dawson","year":"1990","journal-title":"Nature"},{"key":"10.1023\/A:1008301602785_bb0125","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Stern-berg cells","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008301602785_bb0130","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008301602785_bb0135","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.68.9.5602-5612.1994","article-title":"Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMPI: A B cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers","volume":"68","author":"Rowe","year":"1994","journal-title":"J Virol"},{"key":"10.1023\/A:1008301602785_bb0140","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","article-title":"Induction of hcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death","volume":"65","author":"Henderson","year":"1991","journal-title":"Cell"},{"key":"10.1023\/A:1008301602785_bb0145","first-page":"15","article-title":"The cell cycle: Probing new molecular determinants of resistance and sensitivity to cytotoxic agents","volume":"1","author":"Deisseroth","year":"1995","journal-title":"The Cancer Journal, Scientific American"},{"key":"10.1023\/A:1008301602785_bb0150","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt\u2019s lymphoma cells","volume":"6","author":"Rowe","year":"1987","journal-title":"Embo J"},{"key":"10.1023\/A:1008301602785_bb0155","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1073\/pnas.84.15.5384","article-title":"Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63\/latent membrane protein","volume":"84","author":"Thorley-Lawson","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008301602785_bb0160","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1128\/JVI.62.10.3747-3755.1988","article-title":"Epstein-Barr virus-specific cytotoxic T cell recognition of transfectants expressing the virus-coded latent membrane protein LMP","volume":"62","author":"Murray","year":"1988","journal-title":"J Virol"},{"key":"10.1023\/A:1008301602785_bb0165","first-page":"1072","article-title":"Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin\u2019s lymphoma","volume":"143","author":"Hamilton-Dutoit","year":"1993","journal-title":"Correlation of lymphoma phenotype with three distinct patterns of viral latency Am J Pathol"},{"key":"10.1023\/A:1008301602785_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0042-6822(92)91196-2","article-title":"Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein","volume":"190","author":"Chen","year":"1992","journal-title":"Virology"},{"key":"10.1023\/A:1008301602785_bb0175","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/intimm\/5.12.1599","article-title":"IL-10 inhibits apoptotic cell death in human T cells starved of IL\u20132","volume":"5","author":"Taga","year":"1993","journal-title":"Int Immunol"},{"key":"10.1023\/A:1008301602785_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI117315","article-title":"Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells","volume":"94","author":"Taga","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1023\/A:1008301602785_bb0185","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1182\/blood.V86.11.4199.bloodjournal86114199","article-title":"Spontaneous and glucocorticoid induced apoptosis in human mature T lymphocytes","volume":"86","author":"Brunetti","year":"1995","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0190","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V88.7.2549.bloodjournal8872549","article-title":"lnterleukin-10 increases bcl-2 expression and survival in primary human CD34+ hematopietic progenitor cells","volume":"88","author":"Weber-Nordt","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0195","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1182\/blood.V92.9.3381","article-title":"Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells","volume":"92","author":"Voorzanger-Rousselot","year":"1998","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1008301602785_bb0200","first-page":"107","article-title":"Cytokine fusiontoxins show specific potency against Hodgkin lymphoma cells in vitro","volume":"29","author":"Barth","year":"1998","journal-title":"Leuk Lymph"},{"issue":"Suppl 5","key":"10.1023\/A:1008301602785_bb0205","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/annonc\/9.suppl_5.S17","article-title":"Clonality and germinal centre B-cell derivation of Hodgkin-Reed-Sternberg cells in Hodgkin\u2019s disease","volume":"9","author":"Kupers","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008301602785_bb0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/cimm.1994.1304","article-title":"IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in viro","volume":"159","author":"Wang","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1023\/A:1008301602785_bb0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1084\/jem.182.2.477","article-title":"Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL\u201310 homologue, induces local anergy to allogeneic and syngeneic tumors","volume":"182","author":"Suzuki","year":"1995","journal-title":"J Exp Med"},{"key":"10.1023\/A:1008301602785_bb0220","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin\u2019s disease","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008301602785_bb0225","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0230","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008301602785_bb0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-104-6-739","article-title":"Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin\u2019s disease. A report of eight-year results","volume":"104","author":"Bonadonna","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1008301602785_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1008301602785_bb0245","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1023\/A:1008301602785_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with Discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Slat Soc B"},{"key":"10.1023\/A:1008301602785_bb0255","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V88.3.1035.bloodjournal8831035","article-title":"lnterleukin\u201310 gene expression in adult T-cell leukemia","volume":"88","author":"Mori","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0260","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1998.16.3.818","article-title":"Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin\u2019s disease","volume":"16","author":"Loeffler","year":"1998","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1023\/A:1008301602785_bb0265","first-page":"673a","article-title":"A numerical index to predict tumor control in advanced Hodgkin\u2019s disease","volume":"88","author":"Hasenclever","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0270","first-page":"391","article-title":"Programmed cell death (apoptosis) in hematopoiesis","volume":"20","author":"Koury","year":"1992","journal-title":"Exp Hematol"},{"key":"10.1023\/A:1008301602785_bb0275","first-page":"492","article-title":"Hodgkin cells accumulate mRNA (or hcl\u20132","volume":"73","author":"Hell","year":"1995","journal-title":"Lab Invest"},{"key":"10.1023\/A:1008301602785_bb0280","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0046-8177(92)90286-C","article-title":"Expression of the hcl\u20132 oncogene product and chromosomal translocation t(14;18) in Hodgkin\u2019s disease","volume":"23","author":"Lorenzen","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1023\/A:1008301602785_bb0285","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.1993.11.6.1108","article-title":"Prognostic role of serum beta 2-microglobulin in Hodgkin\u2019s disease","volume":"11","author":"Dimopoulos","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008301602785_bb0290","first-page":"3338","article-title":"Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin\u2019s disease","volume":"15","author":"Longo","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V87.2.699.bloodjournal872699","article-title":"Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers","volume":"87","author":"Huhn","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1008301602785_bb0300","first-page":"280a","article-title":"Recombinant human lnterleukin-10 (RHIL-10) \u2013 safety, pharmakodynamics and im-munohematologic effects of repeated daily subcutaneous (s.c.) doses in healthy volunteers","volume":"90","author":"Huhn","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0305","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood.V92.6.1967","article-title":"Interleukin-10 inhibits erytropoietin-independent growth of erythroid bursts in patients with polycythemia vera","volume":"92","author":"Geissler","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008301602785_bb0310","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1200\/JCO.1996.14.6.1928","article-title":"Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin\u2019s disease treated by ABVD plus radiotherapy: Ten-year results of the Paris-Ouest-France 81\/12 trial, including 262 patients","volume":"14","author":"Colonna","year":"1996","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1023\/A:1008301602785_bb0315","first-page":"31","article-title":"Interleukin\u201310 (IL-10) basal serum levels correlate with relapse in Hodgkin disease (HD)","volume":"29","author":"Bonfante","year":"1998","journal-title":"Leuk Lymph"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/4\/433\/19477391\/10-4-433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T04:23:02Z","timestamp":1733545382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419571575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["S0923753419571575"],"URL":"https:\/\/doi.org\/10.1023\/a:1008301602785","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}